ClinicalTrials.Veeva

Menu

Multimodal Imaging in Central Serous Chorioretinopathy (IMO)

C

Centre Hospitalier Universitaire de Besancon

Status

Terminated

Conditions

Central Serous Chorioretinopathy

Treatments

Device: RTX1 IMAGIN EYE retinal camera

Study type

Interventional

Funder types

Other

Identifiers

NCT02889185
P/2015/249

Details and patient eligibility

About

This study aims to assess the contribution of the multimodal imaging, combining a routine examination using Optical Coherence Tomography (OCT) with an imaging procedure using adaptive optics retinal camera.

This is a feasibility study with a limited number of patients.

Enrollment

3 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Signed informed consent form
  • Beneficiary/affiliated to French social security/social healthcare
  • Active ou chronic Central Serous Chorioretinopathy on at least one eye
  • Absence of other known ophthalmological pathology or of any ophthalmological conditions revealed during the examination

Exclusion criteria

  • Legal incapacity or limited legal capacity
  • Predictable poor adherence
  • Subject without health insurance
  • Pregnant or breatfeeding women
  • Sujet étant dans la période d'exclusion d'une autre étude ou prévue par le "fichier national des volontaires"
  • Presence of transparent medium opacity damaging images quality
  • Previous photosensitivity
  • Recent treatment with PhotoDynamic Therapy (PDT)
  • Use of drugs inducing photosensitivity

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

3 participants in 1 patient group

Adaptative optics retinal camera
Experimental group
Treatment:
Device: RTX1 IMAGIN EYE retinal camera

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems